nutch_noindex
CANCELAR
/nutch_noindex

Jeffrey Faig, MD

  • Jeffrey C. Faig

Especialidades

Obstetrics & Gynecology

Trabajo y Educación

Formación Profesional

Yale School Of Medicine Office of Student Affairs, New Haven, CT, 1980

Residencia

Kaiser Permanente Hospital, San Francisco, CA, 1999

Stanford University School of Medicine Registrar, Palo Alto, CA, 1997

Univ of California San Francisco, San Francisco, CA, 1983

Compañerismo

Stanford University School of Medicine Registrar, Palo Alto, CA, 1991

Certificaciones Médicas

Endocrinology, Diabetes & Metabolism, American Board of Internal Medicine

Internal Medicine, American Board of Internal Medicine

Obstetrics & Gynecology, American Board of Obstetrics and Gynecology

Servicios

Obstetricia

Condiciones Tratadas

Diabetes in Pregnancy

Endocrinopathies in Pregnancy

Thyroid Disease in Pregnancy

Todo Publicaciones

Early Screening and Treatment of Women with Prediabetes: A Randomized Controlled Trial. American journal of perinatology Osmundson, S. S., Norton, M. E., El-Sayed, Y. Y., Carter, S., Faig, J. C., Kitzmiller, J. L. 2016; 33 (2): 172-179

Abstract

To examine whether women with prediabetes benefit from early treatment for gestational diabetes mellitus (GDM).Women with a glycosylated hemoglobin A1C (A1C) of 5.7 to 6.4% at <14 weeks were recruited. Participants were randomized to usual care or treatment for GDM with diet, blood glucose monitoring, and insulin as needed. The primary outcome was a 75-g oral glucose tolerance test at 26 to 28 weeks. Secondary outcomes included cesarean delivery, birthweight, weight gain, and A1C change.Between May 2012 and June 2014, 95 women were enrolled and 83 had data for analysis; 42 were randomized to treatment and 41 to usual care. The groups were similar in baseline characteristics with 40% obese. There was no difference in the primary outcome (treatment 45.2% vs. control 56.1%; relative risk [RR] 0.80; 95% confidence interval [CI] 0.53-1.24) except that women in the treatment group had a significantly lower A1C over time than women in the control group (p=0.04). Nonobese women (n=50) treated for GDM experienced a 50% reduction in GDM compared with controls (29.6 vs. 60.9%; RR 0.49; 95% CI 0.25-0.95).Early treatment for women with a first-trimester A1C of 5.7 to 6.4% did not significantly reduce the risk of GDM except in nonobese women.

View details for DOI 10.1055/s-0035-1563715

View details for PubMedID 26344009

Continuous glucose monitoring in pregnancy: new frontiers in clinical applications and research. Journal of diabetes science and technology Sung, J. F., Taslimi, M. M., Faig, J. C. 2012; 6 (6): 1478-1485

Abstract

Current treatment of diabetes in pregnancy relies on intermittent self-monitoring of blood glucoses using finger sticks to monitor capillary blood glucoses. Continuous glucose monitoring (CGM) systems are an emerging technology that allow frequent glucose measurements (every 5 min) and the ability to monitor glucose trends in real time. Although these devices are currently expensive and mildly invasive to use, there is huge potential for their use in both the research and clinical realms. From a research perspective, there is the potential to better understand glucose metabolism in pregnancy, both in patients with and without diabetes. For the treating clinician, CGM has the potential to improve detection of hyperglycemic excursions as well as asymptomatic hypoglycemia and the data to improve management of glucose levels in diabetes patients. In this article, we review current literature examining use of CGM in both research and clinical applications.

View details for PubMedID 23294795

Endocrine Complications of Cancer and Its Treatment: Thyroid and Adrenal Dysfunction Cancer Medicine Faig, J., Hoffman, Andrew R. 1993
CHRONIC ATYPICAL SEIZURE DISORDER AND CATARACTS DUE TO DELAYED DIAGNOSIS OF PSEUDOHYPOPARATHYROIDISM WESTERN JOURNAL OF MEDICINE FAIG, J. C., Kalinyak, J., Marcus, R., Feldman, D. 1992; 157 (1): 64-65

View details for Web of Science ID A1992JD51600012

View details for PubMedID 1413750

RETINITIS PIGMENTOSA AND BRANCH RETINAL ARTERY-OCCLUSION WITH ANTICARDIOLIPIN ANTIBODY ARCHIVES OF OPHTHALMOLOGY CROFTS, J. W., Nussbaum, J. J., Levine, S. R., FAIG, J. C. 1989; 107 (3): 324-324

View details for Web of Science ID A1989T597500011

View details for PubMedID 2923554